The study of the release of active substances from hemostatic agent on hydrophilic basis
https://doi.org/10.31549/2542-1174-2020-1-100-107
Abstract
About the Authors
Yu. N. BarsukovaRussian Federation
Barsukova Yuliya Nikolayevna — Post-Graduate student, Department of Pharmacy and Chemistry
3, Repina Str., Yekaterinburg, 620028
O. A. Melnikova
Russian Federation
Melnikova Olga Aleksandrovna – Dr. Sci. (Pharmaceut.), Assistant Professor, Department of Pharmacy and Chemistry
Yekaterinburg
References
1. Barsukova Yu.N., Melnikova O.A. (2017). State of the pharmaceutical market of hemostatic drugs in the Russian Federation. Proceedings of Voronezh State University; Series: Chemistry, Biology, Pharmacy, 1, 138–142.
2. Belozerskaya G.G., Makarov V.A., Zhitkov E.A. (2006). Hemostatic agents of local action (review). Pharmaceutical Chemistry Journal, 40, 7, 9–15. In Russ.
3. Galanakis I., Vasdev N., Soomro N. (2011). A review of current hemostatic agents and tissue sealants used in laparoscopic partial nephrectomy. Rev. Urol., 13 (3), 131–138.
4. Eaton J.W., Qian M. (2002). Molecular bases of cellular iron toxicity. Free Radic. Biol. Med., 32 (9), 833–840.
5. Raghunathan K., Connelly N.R., Kanter G.J. (2011). ε-Aminocaproic acid and clinical value in cardiac anesthesia. J. Cardiothorac. Vasc. Anesth., 25 (1), 16–19.
6. Demina N.B., Skatkov S.A. (2009). Pharmaceutical nanotechnology: development of technological disciplines in higher pharmaceutical education. Pharmacy, 2, 42–45. In Russ.
7. Ellis-Behnke R.G., Teather L.A., Schneider G.E., So K.F. (2017). Using nanotechnology to design potential therapies for CNS regeneration. Cur. Pharm. Des., 13 (24), 2519–2528.
8. Barsukova Yu.N., Melnikova O.A. (2019). Soft drug dosage form with nanoparticles for control bleeding: justification of composition and technology of preparation. Drug Development and Registration, 8, 2, 48–54. In Russ.
9. Tyukavkina N.A., Berland A.S., Elizarova T.E. et al. (2014). Standardization and Quality Control of Medicines. Moscow, 384 p. In Russ.
10. Stepanova E.F., Koryakov K.N., Khartyunova E.I., Mayorova A.V. (2010). Selection of optimal composition of auxiliary substances of dermatological dosage forms with dimebone: biopharmaceutical research in vitro. International Journal of Applied and Fundamental Researches, 5, 41–45. In Russ.
11. Krówczyński L.S. (1984). Sprawy badań naukowych w dziedzinie technologii postaci leku (1972–1982). Farm. Pol., 40 (1), 21–26.
12. Barsukova Yu.N., Melnikova O.A., Melnikov M.Yu. (2018). Development and validation of spectrophotometric techiques of determination of aminocaproic acid in a multicomponent hemostatic agent. Drug Development and Registration, 1, 76–83. In Russ.
13. Barsukova Yu.N., Melnikova O.A., Melnikov M.Y. (2017). Development and validation of photometric techiques of determination of iron in hemostatic agent. Drug Development and Registration, 1, 86–91. In Russ.
Review
For citations:
Barsukova Yu.N., Melnikova O.A. The study of the release of active substances from hemostatic agent on hydrophilic basis. Journal of Siberian Medical Sciences. 2020;(1):100-107. https://doi.org/10.31549/2542-1174-2020-1-100-107